Gregory Berk

Insider Reports History

Entity
Individual
Location
Hana Biosciences, Inc., 400 Oyster Point Blvd, San Francisco, CA
Signature
/s/ Gregory Berk, M.D.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gregory Berk:

Stock Role Class Num Shares Value Price $ Report Date Ownership
GT Biopharma, Inc. Pres. of R&D, CMO Option to purchase Common Stock 50K Jul 15, 2022 Direct

Insider Reports Filed by Gregory Berk

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GTBP GT Biopharma, Inc. Jul 15, 2022 1 $0 4 Jul 19, 2022 Pres. of R&D, CMO
GTBP GT Biopharma, Inc. Feb 16, 2021 2 $0 4 Feb 14, 2022 Director
GTBP GT Biopharma, Inc. Nov 11, 2020 0 $0 3 Feb 14, 2022 Director